Skip to search formSkip to main contentSkip to account menu

ABT-288

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.
INTRODUCTION ABT-288 is a highly potent histamine-3 receptor antagonist that has demonstrated pro-cognitive effects in… 
2014
2014
A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia.
BACKGROUND ABT-288, a highly selective histamine-3 receptor antagonist, demonstrated efficacy across several preclinical… 
2014
2014
The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.
AIMS ABT-288 is a potent and selective H3 receptor antagonist with procognitive effects in several preclinical models. In… 
2014
2014
A Randomized Study of H 3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer ’ s Dementia 1
Background: ABT-288, a highly selective histamine-3 receptor antagonist, demonstrated efficacy across several preclinical… 
2013
2013
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers.
AIM The objective of this work was to characterize the safety, tolerability and pharmacokinetics of ABT-288, a highly selective… 
2013
2013
Assessment of the abuse liability of ABT-288, a novel histamine H3 receptor antagonist
Histamine H3 receptor antagonists, such as ABT-288, have been shown to possess cognitive-enhancing and wakefulness-promoting… 
2012
2012
Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist
Blockade of the histamine H3 receptor (H3R) enhances central neurotransmitter release, making it an attractive target for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)